Community/Retail

The treatment is currently undergoing evaluation in an investigational preclinical program and is projected to be in human trials in 2026.

Policymakers and health care providers call for reforms to improve transparency, pricing, and patient access.

A brief period of overeating ultra-processed, high-calorie snacks could lead to liver fat accumulation and temporary disruption of brain insulin action.

Efficacy and tolerability of topical treatments can vary by region, particularly sensitive areas such as the face and neck.

Melatonin supplementation could improve oxidative DNA damage repair capacity among night shift workers.

The approval is based on results from 2 phase 3 clinical trials that showed revakinagene taroretcel’s efficacy in macular telangiectasia type 2 (MacTel).

The move is expected to expand clozapine access for patients with schizophrenia.

According to a news release, this marks the first significant innovation in epinephrine delivery for this patient population is more than 35 years.

Unlike other professionals such as nurses and physicians, pharmacists remain tethered to a fragmented state-by-state licensure model that creates unnecessary barriers to care.

Adalimumab biosimilars differ from adalimumab in approved indications, concentration and dosage, and formulation.

Tezepelumab demonstrated efficacy compared with placebo when treating patients with chronic rhinosinusitis with nasal polyps.

The designation was granted after positive results from the phase 1 STOMP-I clinical trial (NCT01915927).

RSV vaccine acceptance among older adults is significantly influenced by perceived benefits.

The FDA is issuing new changes to labels on testosterone products, clarifying that there are no increases in major cardiac events among men with hypogonadism but noting an increase in blood pressure with the use of such products.

The t:slim X2 insulin pump and Tandem Mobi system both use Control-IQ.

The action follows pooled data from 2 studies that enrolled patients with hemophagocytic lymphohistiocytosis (HLH)/macrophage activation syndrome (MAS) in Still disease.

Notable advancements include machine learning and predictive analytics, among others.

The new approval expands the portfolio of denosumab biosimilars, increasing access and improving costs for patients.

ADI-101 targets CD20 for the treatment of autoimmune diseases and is advancing across 6 autoimmune indications.

Learning to strengthen and harness these skills is crucial to making the successful career transition from retail to a hospital pharmacy.

LAIs offer a variety of benefits, from improved medication adherence and relapse prevention to enhanced quality of life for individuals with schizophrenia.

The decisions were made amid the United States worst flu outbreak in over 2 decades.

The feature is expected to be available to US users in late March 2025.

The data were released in the CDC’s Morbidity and Mortality Weekly Report.

Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.

RSV infection resulted in higher costs among specific age groups, especially patients aged 70 to 80 years.

The updated indication now includes pediatric patients aged 5 through 11 years.

Patients with metabolic dysfunction-associated steatohepatitis (MASH) receiving 300 mg of vitamin E daily presented improved steatosis, lobular inflammation, and fibrosis stages.

Health care professionals and patients must recognize that rapid administration of adrenaline is the only first-line treatment for anaphylaxis.

If approved, gepotidacin (GSK) will be a new oral agent added to the treatment paradigm for urinary tract infections (UTIs).